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Tribromoethanol (2,2,2-tribromoethanol, TBE) is a popular injectable anesthetic agent used in mice in
Korea. Our goal was to assess the risks associated with side effects (lesions) in the abdominal cavity,
especially at high doses. To understand the underlying pathophysiological changes, we examined levels of
cytokines through ELISA of abdominal lavage fluid and spleen collected from mice treated with low and
high-dose TBE. ICR mice were anesthetized using one of the following protocols: a combination of TBE
200 mg/kg (1.25%) and xylazine 10 mg/kg; TBE 400 mg/kg (1.25%); and TBE 400 mg/kg (2.5%).
Administration of high-dose TBE (400 mg/kg) increased the interleukin-1β and interleukin-6 levels in the
peritoneal cavity over the short term (<1 day) compared with sham controls and low-dose TBE (200 mg/
kg) groups. Cytokine expression in the low-dose TBE group was similar to the control group, whereas in
the high-dose TBE group cytokine levels were higher in abdominal lavage fluid and spleen over the long
term (10 days post-injection). We conclude that a combination of TBE 200 mg/kg (1.25%) and xylazine (10
mg/kg) is a safe and effective anesthetic for use in animals.
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Tribromoethanol (2,2,2-tribromoethanol, TBE) has the ability
to rapidly induce deep anesthesia followed by a rapid and
complete recovery [1]. As a result of a TBE preparation
experiment performed to determine an adequate dose of
TBE, we determined whether inducing anesthesia with a TBE
injection alone can cause adverse effects due to the toxicity
of the chemical, including retention of food in the digestive
tract, peritonitis and fibrinoid adhesions. TBE is an irritant,
especially at high concentrations or with repeated use.
Anesthesia with TBE can result in ileus, abdominal adhesions,
increased generalized morbidity, and increased mortality [2-
8]. Since TBE produces various side effects, it has been
recommended only for acute terminal studies when
administrated intraperitoneally (IP) to laboratory animals [9].
While such adverse effects have been found in earlier studies
[5,6,8], some recent studies claimed that they could not find
any adverse effects [1].
In preliminary experiments, all animals that were injected
with a low dose of 1.25% TBE (200 mg/kg) displayed clear
signs of light anesthesia with a strong pedal withdrawal reflex.
Despite the good anesthetic effect, severe adverse effects
were displayed at 2.5% TBE (400 mg/kg). A mixture of 1.25%
TBE (200 mg/kg) and xylazine (10 mg/kg) appeared to be
safe and provided satisfactory anesthesia in ICR mice [10].
There has been relatively little information in the literature
regarding proinflammatory cytokine expression in abdominal
lavage fluid and spleen lymphoid tissues [1,6,8,11]. In an
attempt to reduce the side effects of TBE, Gopalan et al
[2] used a combination of a lower dose of TBE and
medetomidine in Sprague-Dawley (SD) rats [2]. In the present
study we tested a different anesthetic combination, TBE and
xylazine (an α2-adrenergic agonist that has sedative, muscle-
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relaxation, and analgesic properties) in ICR mice [12]. No
published reports indicated significant proinflammatory
cytokine expression in abdominal lavage fluid and spleen
[1,6,8,11]. Inflammation involves production and release of
inflammatory mediators, including three major groups of:
proinflammatory, chemotactic, and anti-inflammatory
cytokines [13]. Classically activated macrophages secrete
proinflammatory cytokines, such as tumor-necrosis factor-α
(TNF-α), interleukin-1β (IL-1β), and IL-6 [14,15]. In mice,
TNF-α is the first inflammatory cytokine to be produced de
novo. It induces synthesis of IL-1β [16]. IL-1β is the only
IL-1 species present during acute experimental inflammation
in mouse peritoneal exudates [17]. Functionally, TNF-α and
IL-1β are closely related; they act synergistically to induce
the expression of chemokines and up-regulate cell adhesion
molecules, thus triggering leukocyte emigration to the
inflammatory site [13].
Although 1.25% TBE (12.5 mg/mL) is typically used in mouse
experiments, we had to increase the concentration to 2.5%
(25 mg/mL) for the 400 mg/kg dose to make it adequate for
IP administration. For example, in order to administer 400
mg/kg of 1.25% TBE to a 25 g mouse, 0.8 mL is required,
which exceeds the recommended quantity (0.5 mL or less)
and can potentially cause adverse effects [18]. It was difficult
to confirm whether the adverse effects displayed in the group
administered 2.5% TBE 400 mg/kg were caused by the
concentration or by the dose of TBE. Hence, we determined
whether a connection exists between tribromoethanol
concentration and dosage in peritonitis.
In the present study, our goals were (1) to measure bacterial
growth in abdominal lavage fluid of anesthetized mice and
(2) to investigate the direct influence of proinflammatory
cytokines (IL-1β, IL-6, and TNF-α) in abdominal lavage fluid
and spleen.
Materials and Methods
Animals
Male ICR mice (n=48; weight, 20 to 29 g; 4-6 weeks
old) were obtained from NaraBiotech (Pyeongkaek, Korea).
These mice were free of common rodent viruses, bacteria,
and parasites. Animals were housed in a barrier facility in
individual ventilated caging systems with β-chip bedding on
a 12:12-h light:dark cycle. The room temperature was 23±1
oC, with relative humidity of 50±5% and with 25 complete
changes of filtered air per hour. Animals housing was five
mice per cage. Gamma-sterilized fomula-m07 food (Feed
Lab, Guri, Korea) and autoclaved tap water by bottle were
provided ad libitum. Animal care and experimental procedures
were approved by the animal care and use committee of
Konkuk University and were in accordance with published
National Institutes of Health guidelines [19].
TBE recipe
Commercially available 2,2,2-tribromoethanol powder
(T48402; Sigma-Aldrich, St. Louis, MO, USA) was used for
all studies. To prepare a 1 g/mL stock solution, a measured
amount of TBE powder was placed into a 50 mL polypropylene
conical tube (Becton Dickinson Labware, Franklin Lakes, NJ,
USA) that was wrapped in aluminum foil. A micro-pipette
was used to add t-amyl-alcohol (TAA, 240486; Sigma-Aldrich),
and the solution was vortexed until it dissolved at room
temperature (25
oC). To prepare fresh dilutions of TBE (200
and 400 mg/kg) in volumes of 0.35-0.50 mL, an appropriate
volume of sterilized phosphate-buffered saline (PBS, P5368;
Sigma-Aldrich) was added to a stock solution and vortexed
until the whole stock solution was dissolved in PBS at 25
oC.
Working solutions were filtered using sterile technique with
a 0.20 µm disposable syringe filter unit (Mixed Cellulose Ester,
ADVANTEC
®, Toyo Roshi Kaisha, Ltd., Tokyo, Japan). Using
filtering, working solutions were obtained and placed in
sterilized glass tubes capped with rubber stoppers and wrapped
in aluminum foil. The preparer wore gloves, glass vials were
autoclaved, and all glassware was triple-rinsed with distilled
water before being autoclaved. Newly prepared TBE solution
was stored in the dark at 4
oC.
Experimental design
All animals received a single IP injection using a 26G 1-
mL syringe in the lower-right quadrant of the mice’s abdomen
[20,21]. Details of the anesthetic protocols are given in Table
1. Animals were weighed and given one of the anesthetic
combinations. The animal was placed back in its home cage
until it lost its righting reflex. Once the righting reflex was
lost, mice were maintained on a temperature-controlled
heating platform (38
oC, Jungdo B&P , Seoul, Korea), and their
eyes were lubricated with ointment (Solco
®, Hanlim Pharm
Co., Ltd., Seoul, Korea). Assessment of the pedal withdrawal
reflex was performed to ensure that the animal was maintained
at the correct depth of anesthesia. To apply pressure uniformly,
the pedal withdrawal reflex was assessed using a Touch-Test
TM
sensory evaluator (North Coast Medical Inc., San Jose, CA,
USA) with a target force of 300 g, which indicates deep
pressure sensation, every 5 min [4]. For the pedal withdrawal
reflex, the mouse's hind limb was slightly extended and the
interdigital webbing was touched by the sensory evaluator.
A clear attempt to withdraw the limb was judged a positive
reaction. All animals breathed room air for the duration ofTribromoethanol and kinetics of proinflammatory cytokines 199
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the experiment. Mice were monitored for clinical signs of
illness such as lethargy, unkempt hair coat, hunched posture,
or dehydration. At 4 h post-injection (HPI) and 1, 4 and
10 days post-injection (DPI), three mice from each group
were sacrificed.
Sample collection for ELISA
Animals were deeply anesthetized with isoflurane at each
time point after injection. The peritoneal cavity was lavaged
with 2 mL sterile saline, each mouse received a 10-sec gentle
manual massage, and exudates (>1 mL) were retrieved,
centrifuged at 2,000 g for 10 min, and frozen at −80
oC
for later cytokine assessment [22]. Animals were then
exsanguinated by placing a needle in the caudal vena cava.
The spleen was excised aseptically and homogenized in
1×PBS (100 mg/mL) using a homogenizer (T10 basic ULTRA-
TURRAX
®, IKA Laboratory Equipment, Staufen, Germany) and
centrifuged at 14,000 rpm for 10 min at 4
oC [23]. Supernatant
was collected, aliquoted and stored at −80
oC for further use
in ELISA.
Measurement of peritoneal bacterial load
Bacterial counts were done for aseptically harvested
peritoneal fluid at each time point after injection. Abdominal
lavage fluid (0.1 mL) obtained to assess cytokines was cultured
on tryptic soy agar plates (HiMedia
 Laboratories Limited, LBS
Marg, Mumbai, India). Plates were incubated (37
oC) for 48 h,
and bacterial growth was investigated.
ELISA
To examine secreted and local cytokine production, cytokine
specific ELISA was performed on abdominal lavage fluid and
on extracted proteins from spleens in each group.
Commercially-available kits from Biosource (Invitrogen,
Carlsbad, CA, USA) were used per the manufacturer’s
guidelines. In each cytokine specific ELISA, we used 10 mg
of the total extracted protein of the spleen.
Statistical analysis
All statistical analyses were carried out using SPSS version
14.0K and GraphPad Prism version 4.00 for Windows
(GraphPad Software, San Diego, CA, USA). All data were
presented as means±SEM. Comparisons of the two different
anesthesia groups were made by Student’s unpaired t-tests.
One-way analysis of variance (ANOVA) was performed with
Tukey’s adjustment for multiple comparisons to evaluate
differences among each anesthetic group for cytokine
expression level. A value of P<0.05 was considered significant.
Results
Measurement of peritoneal bacterial load
No bacteria were detected in abdominal lavage fluid of
mice after a 48-h culture.
Clinical signs
By 10 days after anesthetic administration, all strains in
group 2 also manifested the following clinical signs of disease:
dehydration, disheveled appearance, porphyrin staining of
the eyes and nose, and hunched posture. Grossly, ICR mice
in protocols 2 and 3 had evidence of ileus and thin abdominal
walls at 1 and 4 DPI. Six and eight ICR mice in protocols
2 and 3 had focally extensive areas of fibrous adhesions
between the abdominal wall, cecum, and small intestine,
which were filled with gas and/or fluid at 10 DPI.
Cytokine estimation in abdominal lavage fluid
The amount of secreted cytokines in the abdominal lavage
fluid was expressed as pg protein/mL (Table 2). Mice in protocol
2 showed a significant increase in IL-1β levels (131.5±20.8
pg/mL) in comparison to sham animals (28.6±4.7 pg/mL)
and protocol 1 (43.1±19.7 pg/mL) at 4 HPI (P<0.05). Mice
in protocol 2 showed a significant increase in IL-1β levels
(83.4±1.6 pg/mL) in comparison to sham (10.5±0.6 pg/mL)
and protocol 1 (12.7±1.6 pg/mL) at 4 DPI (P<0.05). Mice
in protocol 3 showed a significant increase in IL-1β levels
(190.1±21.3 pg/mL) in comparison to sham control and
protocol 1 at 4 HPI (P<0.05). Significant differences were
found in IL-1β expression between (a) protocol 3 (145.5±18.2
pg/mL) and (b) control mice (26.7±6.1 pg/mL), protocol 1
mice (16.8±0.7 pg/mL) and protocol 2 mice (76.0±11.6 pg/
mL) at 1 DPI, but not at 4 and 10 DPI (P<0.05) (Table 2).
Table 1. Summary of experiments and number of animals used
Protocol Substance and dose (mg/kg) Number of animals
Sham PBS (0.5 mL/per animal) 12
1 1.25% tribromoethanol 200 mg/kg+xylazine* 10 mg/kg 12
2 1.25% tribromoethanol 400 mg/kg 12
3 2.5% tribromoethanol 400 mg/kg 12
*Rompun
®, Bayer Health Care, Seoul, Korea.200 Yoon Ju Cho et al.
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Mice in protocol 2 showed a significant increase in IL-6
levels (1,465.4±432.8 pg/mL) in comparison to sham (130.2±
92.1 pg/mL) and protocol 1 (209.3±48.9 pg/mL) at 4 HPI
(P<0.05). Significant differences were found in IL-6 expression
between (a) protocol 3 (2786.0±364.2 pg/mL) and (b) control
(130.2±92.1 pg/mL), protocol 1 (209.3±48.9 pg/mL) and
protocol 2 (1465.4±432.8 pg/mL) at 4 HPI (P<0.05). IL-6
was not secreted in detectable amounts in control and protocol
1 at 4 and 10 DPI as well as protocol 3 at 10 DPI (Table 2).
TNF-α expression showed no significant difference between
controls and the other groups at any time (Table 2).
Cytokine estimation in spleen
Cytokines production was expressed as pg/mL supernatant
of spleen (Table 3). A significant difference was found in IL-
1β expression between sham and protocol 3 mice spleen
at 1, 4 and 10 DPI (P<0.05). IL-1β production in protocol
1 (126.8±6.6 and 116.9±11.1 pg/mL) was less than that in
protocol 3 (235.2±15.5 pg/mL) at 4 DPI and less than that
in protocol 2 (216.4±13.1 pg/mL) at 10 DPI (P<0.05). Mice
in protocol 2 showed a significant increase in IL-1β levels
(219.9±1.8 and 216.4±13.1 pg/mL) in comparison to sham
(114.0±10.8 and 112.6±14.3 pg/mL) at 4 and 10 DPI
(P<0.05).
A nearly constant amount of IL-6 was expressed at all days
in protocol 2 (84-92 pg/mL) and protocol 3 [110-113 pg/
mL]. IL-6 production in the sham group was higher (152.2±6.5
pg/mL) than in protocols 1, 2 and 3 (98.0±6.8, 89.2±2.5
and 113.6±3.6 pg/mL, respectively) at 4 HPI (P<0.05) but
not at 1, 4 and 10 DPI. A significant increase was presented
Table 2. Cytokine levels (pg/mL) quantitated by ELISA in the abdominal lavage fluid after intraperitoneal administration at various
time points
Time points 4 hours 1 day 4 days 10 days
IL-1β
Sham 28.6±4.70 26.7±6.10 10.5±0.60 ND
P1 43.1±19.7 16.8±0.70 12.7±1.60 ND
P2 131.5±20.8* 76.0±11.6 83.4±1.6* 107.5±4.100
P3 190.1±21.3* 145.5±18.2
†. 57.8±1.20 68.8±10.2
IL-6
Sham 130.2±92.10 15.7±6.40 ND ND
P1 209.3±48.90 12.2±1.80 ND ND
P2 1465.4±432.8*
. 68.2±30.5 8.4
a 19.9
a
P3 2786.0±364.2
† 412.7±29.3
b. 25.5±5.3
b ND
TNF-α
Sham 8.8±0.2 10.5±1.70 4.7±1.9 ND
P1 28.5±16.5 7.3±0.1 6.9±0.0 ND
P2 21.5±6.60 29.0±15.9 9.7±1.4 19.1±4.00
P3 24.2±3.50 15.2±1.50 7.9±0.9 11.9±2.80
Values represent mean±SEM (n=3). Sham: 0.5 mL PBS-injected group, P1: 1.25 % tribromoethanol (TBE) 200 mg/kg+xylazine 10 mg/
kg, P2: 1.25 % TBE 400 mg/kg, P3: 2.5 % TBE 400 mg/kg, ND: not detected.
 an=1; 
b n=2. *P<0.05 vs sham control and protocol
1. 
†P<0.05 vs sham control and protocols 1 and 2.
Table 3. Cytokine levels (pg/mL) quantitated by ELISA in the spleen after intraperitoneal administration at various time points
Time points 4 hours 1 day 4 days 10 days
IL-1β
Sham 398.6±22.3 182.3±22.0 114.0±10.8 112.6±14.3
P1 304.9±3.6 240.6±32.3 126.8±6.6 116.9±11.1
P2 351.3±16.4 272.7±5.8 219.9±1.8* 216.4±13.1
†
P3 308.1±1.5 310.8±13.5* 235.2±15.5
† 208.7±4.2*
IL-6
Sham 152.2±6.5 068.1±10.5 045.2±5.9 033.3±2.9
P1 098.0±6.8* 092.6±11.3 055.7±2.0 027.8±3.2
P2 089.2±2.5* 086.6±2.4 084.0±2.1* 092.3±5.5
†
P3 113.6±3.6* 113.3±13.7* 115.1±2.1
† 110.9±5.3
†
TNF-α
Sham 371.1±26.0 095.9±17.2 032.0±5.4 015.6±0.4
P1 272.0±13.0* 161.4±45.4 049.7±1.8 015.2±0.3
P2 093.1±15.7
† 081.8±2.2 101.8±9.4 082.4±14.2
†
P3 194.2±20.8* 124.9±8.5 086.7±0.2 080.2±3.1
†
Values represent mean±SEM (n=3). Sham: 0.5 mL PBS-injected group, P1: 1.25 % tribromoethanol (TBE) 200 mg/kg+xylazine 10 mg/
kg, P2: 1.25 % TBE 400 mg/kg, P3: 2.5 % TBE 400 mg/kg, ND: not detected.
 *P<0.05 vs sham control. 
†P<0.05 vs sham control
and protocols 1.Tribromoethanol and kinetics of proinflammatory cytokines 201
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in protocol 3 mice compared with sham at 1, 4 and 10
DPI (P<0.05). The level for protocol 2 (84.0±2.1 pg/mL)
was significantly higher than for sham (45.2±5.9 pg/mL) at
4 DPI. The level for protocol 2 (92.3±5.5 pg/mL) was
significantly higher than for sham (33.3±2.9 pg/mL) and for
protocol 1 (27.8±3.2 pg/mL) at 10 DPI (P<0.05). A significant
increase was present in protocol 3 mice in comparison with
protocol 1 mice at 10 DPI (P<0.05).
In the spleen of sham controls (371.1±26.0 pg/mL) at 4
HPI, TNF-α levels were significantly higher than for protocol
1, 2, and 3 mice (272.0±13.0, 93.1±15.7, and 194.2±20.8
pg/mL, respectively). However, protocol 2 and 3 mice had
significantly higher values (82.4±14.2 and 80.2±3.1 pg/mL,
respectively) than sham and protocol 1 mice (15.6±0.4 and
15.2±0.3 pg/mL, respectively) at 10 DPI (P<0.05).
Discussion
To understand the underlying pathophysiological changes,
we examined the level of cytokines and protein levels through
ELISA experiments with abdominal lavage fluid and spleen
fluid collected from mice treated with low-dose TBE. TBE
at 400 mg/kg was a reliable anesthetic that provided surgical
anesthesia for approximately 40 min in ICR mice [10].
However, it is recommended that one does not increase
the TBE dose since fibrous adhesions in the abdominal cavity,
irritation, and mortalities have been reported, especially with
high doses or repetitive use [2]. The combination of 200
mg/kg TBE and 10 mg/kg xylazine induced proper anesthetic
depth in ICR mice [10]. The dose of 400 mg/kg TBE used
in protocol 2 was based on doses reported in the literature
[1,8,24]. While the lowest dose of TBE that resulted in adequate
anesthesia, based on the toe-pinch reflex, was a dose of
375 mg/kg, the lowest dose that consistently produced
adequate anesthesia in all ICR mice tested was 400 mg/kg
[4]. However, fibrous adhesions between the abdominal wall,
cecum, and small intestine, which were filled with gas and/
or fluid, were observed in all mice strains for protocol 2.
These side effects are induced by TBE per se and not related
to the solvent used [6,8]. External stimuli such as peritoneal
insults that induce inflammatory cascades, subsequently
caused a reduction in gastrointestinal motility [25]. Therefore,
in the present study, local inflammation in the peritoneal
cavity can be postulated as the cause.
In this study, local cytokine production was investigated
in spleen and abdominal lavage fluid for TBE-administered
mice using intraperitoneal injection. The use of anesthesia
induces a disturbed balance of pro- and anti-inflammatory
cytokines in certain states [26]. To the best of our knowledge,
it is the first study to examine changes in cytokine profiles
in these samples using the IP route for TBE anesthetics in
mice. In the present study, spleen was used because it is
an organ that is a prominent marker in different peritonitis
models and therefore can be used as an abdominal organ
representative of other lymphatic organs [27].
The injection of a wide range of irritants into the peritoneal
cavity induces the hallmarks of inflammation, including pain,
leukocyte infiltration, and synthesis of inflammatory mediators
[28]. IL-1β, IL-6, and TNF-α were selected as proinflammatory
mediators. These cytokines are essential in helping to initiate
and potentiate inflammatory responses [29]. For example,
IL-1β and IL-6 are accepted as markers for tissue reactions
and inflammation in pain-induced stress, and for mechanical
trauma or surgical stress, respectively. TNF-α is a marker for
bacterial endotoxin or enterotoxin-induced immune stimulation
[30,31]. The peritoneum is mainly protected by the innate
immune system [32]. Peritoneal insults induce the influx of
polymorphonuclear neutrophils [14]. Peritoneal mesothelial
cells participate during the recruitment of phagocytes in to
the peritoneal cavity by responding to macrophage-derived
cytokines TNF-α and IL-1β [14].
Surprisingly, there was no increased expression of IL-1β
and IL-6 in TBE-treated groups compared with sham, but
a decrease in TNF-α expression at 4 HPI in spleen. These
results are in close agreement with those of previous studies
comparing cytokine mRNA levels in the spleen of rats injected
with 400 mg/kg TBE [27]. In this context, Bette et al [27]
reported that a single injection of high-dose TBE did not
initiate ‘chemically-induced peritonitis’ by inflammation or
infection in the abdomen [27]. However, this result showed
that these cytokines in sham control and protocol 1 mice
sharply declined from 1 to 10 DPI in spleen. Proinflammatory
cytokines of protocol 2 and 3 in spleen were significantly
higher than sham and protocol 1 at 4 and 10 DPI. Prolonged
stimulation of the inflammatory response may lead to tissue
damage and there is evidence linking mice incapable of
producing IL-6 with decreased mortality and inflammatory
responses when they are injected IP with zymosan [33,34].
It was speculated that there is a correlation between late
effects in these cytokine levels and histopathological changes
of abdominal organs [10].
In addition, to confirm a correlation between pathologic
changes and concentrations of TBE, we compared protocol
2 (1.25% TBE 400 mg/kg) with protocol 3 (2.5% TBE 400
mg/kg) regarding these proinflammatory cytokines. Cytokine
levels of protocol 3 were substantially increased compared
with protocol 2 in abdominal lavage fluid and spleen at each
time point.202 Yoon Ju Cho et al.
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IP drug delivery is overused in rodent studies and carries
many concerns such as contamination, splenic trauma, serosal
hemorrhage, drug delivery into visceral organs or fat pads,
urinary bladder, muscle, and other untoward effects [12].
Some believe that the intestines cannot be penetrated by
an IP injection because they are free to move away from
the needle, whereas about 10 to 20% of IP injections are
placed somewhere other than the peritoneal cavity [21,35].
In an attempt to confirm correct placement, most texts advise
gently withdrawing the syringe plunger before administering
the dose. The disadvantage of this is that, although urine
will be readily aspirated, intestinal or cecal contents are not
easy to be aspirated through the gauge of needle normally
used. There will also be no indication that the needle has
penetrated fat or muscle [36]. Indeed, IP injections have been
described as ‘injections into a black box’, because the error
in IP injections may not be recognized [37]. Hence, the skill
of the technician will be critical to ensure accurate delivery.
In this experiment, correct administration could be directly
assessed by whether animals reached a deep anesthetic stage.
If such failures had been detected, the subject would have
been omitted from the experiment.
Physiologic parameters such as changes in respiratory rate,
heart rate, or blood pressure are the most sensitive, objective,
and quantitative indicators of anesthetized animals [12]. Such
an approach is routinely used in human and companion
animal anesthesia, whereas it is not possible for routine
laboratory experiment with mice because of the requirement
of specialized equipment for the small size of the animal
and its extreme physiologic value [11]. Reflex assessment is
easy to carry out and is considered an acceptable method
and can be done without extensive equipment [38,39]. The
pedal withdrawal reflex used in this study is the most suitable
and reliable parameter to gauge surgical tolerance [11,39-
41]. The hindlimb reflex is a more reliable indicator of
anesthetic depth than the forelimb. It is more sensitive than
a cutaneous reflex and a tail pinch reflex test [40]. Cutaneous
reflexes showed only moderate sensitivity at an early stage
of sedation, and tail pinch reflexes were unable to determine
any of the stages of anesthesia [41]. In this study, to reduce
sources of variation in response to the pedal withdrawal reflex,
the same operator took measurements and assessed reflexes.
Bacterial translocation in a non-lethal rat model of zymosan-
induced sterile peritonitis was detected in peritoneal fluid
[34]. Zymosan particles, the insoluble polysaccharides (β-
glucan and α-mannan components) of the cell walls of
Saccharomyces cerevisiae, are commonly used for induction
of acute peritonitis in mice [16,17,42-45]. Bacterial
translocation is known as the passage of viable resident bacteria
and macromolecules from the gut to the normally sterile intra-
abdominal tissues [46]. In this study, no bacteria were cultured
from the peritoneal fluid at any time points, but we are limited
to culturing aerobic not anaerobic bacteria. However, in a
previous study, bacterial growths from peritoneal fluid were
detected simultaneously in aerobic and anaerobic culture
environments [34]. Therefore, it is conceivable that aerobic
bacteria detection alone is enough evidence whether TBE-
induced peritonitis is the sterile inflammatory or not.
In conclusion, these data show that the effects of
intraperitoneally-injected TBE on the immune system should
always be considered. Hence, the usage of 400 mg/kg TBE
should be avoided when studies are being designed to analyze
long-term (10 days) as well as short-term (<1 day) effects
on the immune system. In addition, the decreased cytokine
level in the low-dose TBE+xylazine group means that this
anesthetic regime is safe in terms of correlation between
pathologic changes and concentration of TBE.
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